Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 293

1.

Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa.

Kaye WH, Greeno CG, Moss H, Fernstrom J, Fernstrom M, Lilenfeld LR, Weltzin TE, Mann JJ.

Arch Gen Psychiatry. 1998 Oct;55(10):927-35.

PMID:
9783564
2.

Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa.

Frank GK, Kaye WH, Ladenheim EE, McConaha C.

Appetite. 2001 Aug;37(1):9-14.

PMID:
11562153
3.

Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa.

Kaye W, Gendall K, Strober M.

Biol Psychiatry. 1998 Nov 1;44(9):825-38. Review.

PMID:
9807638
4.

Eating-related concerns, mood, and personality traits in recovered bulimia nervosa subjects: a replication study.

Stein D, Kaye WH, Matsunaga H, Orbach I, Har-Even D, Frank G, McConaha CW, Rao R.

Int J Eat Disord. 2002 Sep;32(2):225-9.

PMID:
12210666
5.
6.

Altered dopamine activity after recovery from restricting-type anorexia nervosa.

Kaye WH, Frank GK, McConaha C.

Neuropsychopharmacology. 1999 Oct;21(4):503-6.

7.

Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls.

Engström G, Alling C, Blennow K, Regnéll G, Träskman-Bendz L.

Eur Neuropsychopharmacol. 1999 Sep;9(5):399-405.

PMID:
10523046
8.

Association of serotonin and cortisol indices with childhood abuse in bulimia nervosa.

Steiger H, Gauvin L, Israël M, Koerner N, Ng Ying Kin NM, Paris J, Young SN.

Arch Gen Psychiatry. 2001 Sep;58(9):837-43.

PMID:
11545666
9.

Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes.

Jimerson DC, Lesem MD, Kaye WH, Brewerton TD.

Arch Gen Psychiatry. 1992 Feb;49(2):132-8.

PMID:
1372494
11.

Association of the promoter polymorphism -1438G/A of the 5-HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosa.

Bruce KR, Steiger H, Joober R, Ng Ying Kin NM, Israel M, Young SN.

Am J Med Genet B Neuropsychiatr Genet. 2005 Aug 5;137B(1):40-4.

PMID:
15999344
12.

HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses.

Lappalainen J, Long JC, Virkkunen M, Ozaki N, Goldman D, Linnoila M.

Biol Psychiatry. 1999 Sep 15;46(6):821-6.

PMID:
10494451
13.
14.

Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.

Brewerton TD, Mueller EA, Lesem MD, Brandt HA, Quearry B, George DT, Murphy DL, Jimerson DC.

Arch Gen Psychiatry. 1992 Nov;49(11):852-61.

PMID:
1444722
15.

Symptomatic relapse in bulimia nervosa following acute tryptophan depletion.

Smith KA, Fairburn CG, Cowen PJ.

Arch Gen Psychiatry. 1999 Feb;56(2):171-6.

PMID:
10025442
16.

Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa.

Levitan RD, Kaplan AS, Joffe RT, Levitt AJ, Brown GM.

Arch Gen Psychiatry. 1997 Jun;54(6):521-7.

PMID:
9193192
17.

CSF oxytocin and vasopressin levels after recovery from bulimia nervosa and anorexia nervosa, bulimic subtype.

Frank GK, Kaye WH, Altemus M, Greeno CG.

Biol Psychiatry. 2000 Aug 15;48(4):315-8.

PMID:
10960163
18.

Bulimia nervosa with co-morbid avoidant personality disorder: behavioural characteristics and serotonergic function.

Bruce KR, Steiger H, Koerner NM, Israel M, Young SN.

Psychol Med. 2004 Jan;34(1):113-24.

PMID:
14971632
19.

Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.

Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S.

Biol Psychiatry. 1983 Oct;18(10):1141-52.

PMID:
6197099
20.

Cerebrospinal fluid and behavioral changes after methyltestosterone administration: preliminary findings.

Daly RC, Su TP, Schmidt PJ, Pickar D, Murphy DL, Rubinow DR.

Arch Gen Psychiatry. 2001 Feb;58(2):172-7.

PMID:
11177119

Supplemental Content

Support Center